Efb released by intracellular Staphylococcus aureus suppresses host immunity by targeting TRAF3
Xiaokai Zhang,Tingrong Xiong,Lin Gao,Yu Wang,Luxuan Liu,Tian Tian,Yun Shi,Zhang Jinyong,Zhuo Zhao,Dongshui Lu,Ping Luo,Ping Cheng,Weijun Zhang,Haiming Jing,Qiang Gou,Hao Zeng,Dapeng Yan,Quanming Zou
DOI: https://doi.org/10.21203/rs.3.rs-1269383/v1
2022-01-01
Abstract:Many pathogens secrete effectors to hijack intracellular signaling regulators in host immune cells to promote pathogenesis. However, the pathogenesis of Staphylococcus aureus (S. aureus) secretory effectors within host cells is unclear. Here, we report that intracellular S. aureus secretes fibrinogen binding protein (Efb) into the cytoplasm of macrophages to inhibit proinflammatory cytokine expression and suppress host immunity. Mechanistically, RING finger protein 114, a host E3 ligase, mediates K27-linked ubiquitination of Efb at lysine 71, which facilitates the recruitment of TNF receptor associated factor 3 (TRAF3). The binding of Efb to TRAF3 disrupts the formation of the TRAF3/TRAF2/cIAP1 complex, which mediates K48-ubiquitination of TRAF3 to promote degradation, resulting in suppression of the inflammatory signaling cascade. Additionally, the Efb K71R mutant loses the ability to inhibit inflammation and exhibits decreased pathogenicity. Therefore, our findings identify an unrecognized mechanism of S. aureus to suppress host defense, which may be a promising target for developing effective anti-S. aureus immunomodulators.